Media centerClara Prieto2024-03-04T17:33:54+01:00

MEDIA CENTER

Keep up to date with our latest news and resources

PRESS RELEASES

Catch up with the latest updates from our company

mAbxience Appoints Jurgen Van Broeck as New CEO

Miguel Martínez-Cava2024-05-09T09:42:26+02:00May 9, 2024|Press releases|

mAbxience and Teva Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate

Miguel Martínez-Cava2024-04-04T14:38:15+02:00April 4, 2024|Press releases|

mAbxience and Biosidus Sign CDMO Agreement for the Manufacture of Agalsidase Beta for the Treatment of Fabry Disease

Miguel Martínez-Cava2024-02-05T11:58:27+01:00February 5, 2024|Press releases|

BLOG

Dive into the insights from mAbxience, written by our team

GMP certification: ensuring quality in biopharmaceutical production

Clara Prieto2024-08-26T10:08:45+02:00August 26, 2024|News|

Discover the hidden opportunities: real stories of growth at mAbxience

Clara Prieto2024-08-14T12:28:54+02:00August 14, 2024|News|

Mastering biopharma: expert know-how, single-use systems and adaptable manufacturing

Clara Prieto2024-07-31T16:52:12+02:00July 31, 2024|News|

MULTIMEDIA

Browse our media resources and materials

mAbxience | INFOGRAPHIC

Similarity Exercise | VIDEO

mAbxience Biosimilar Development | VIDEO

mAbxience León site | VIDEO

mAbxience Argentina | VIDEO

mAbxience | VIDEO